Brentuximab Vedotin [brentuximab vedotin]
topical
40
- Terms
-
Adcetris
cAC10-vcMMAE
SGN-35
-
Adcetris
CAC10-1006
cAC10-vcMMAE
SGN-35
Persistent link
https://www.medvik.cz/link/D000079963
Definition
Immunoconjugate that consists of the chimeric monoclonal anti - CD30 ANTIGEN antibody cAC-10 conjugated to monomethyl auristatin E. It is used for the treatment of LYMPHOMA.
- DUI
- D000079963 MeSH Browser
- CUI
- M0551563
- History note
- 2020 (2010)
- Public note
- 2020; BRENTUXIMAB VEDOTIN was indexed under IMMUNOCONJUGATES 2010-2019
Allowable subheadings
- AD
- administration & dosage 5
- AE
- adverse effects 3
- AN
- analysis 0
- BI
- biosynthesis 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CH
- chemistry 0
- CL
- classification 0
- DE
- drug effects 0
- EC
- economics 0
- GE
- genetics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 0
- PD
- pharmacology 6
- PH
- physiology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- TU
- therapeutic use 18
- TO
- toxicity 1
- UL
- ultrastructure 0
- UR
- urine 0
...
Occurrences in Medvik records
D
Chemicals and Drugs
D12.644.456.120
Antipain
D12.644.456.726
Peptichemio
D12.644.456.729
Peptide T
D12.644.456.810
Teprotide
D12.644.456.830
Tetragastrin